Ironwood Pharmaceuticals (IRWD) Other Non-Current Assets (2010 - 2026)

Ironwood Pharmaceuticals (IRWD) has 17 years of Other Non-Current Assets data on file, last reported at $4.1 million in Q1 2026.

• For the quarter ending Q1 2026, Other Non-Current Assets fell 25.3% year-over-year to $4.1 million; the trailing twelve-month figure through Mar 2026 stood at $4.1 million (down 25.3% YoY), and the FY2025 full-year result was $4.5 million, down 23.99% from the prior year.
• Other Non-Current Assets declined to $4.1 million in Q1 2026, from $4.5 million in the prior quarter.
• In the past five years, Other Non-Current Assets ranged from a high of $6.3 million in Q3 2024 to a low of $485000.0 in Q2 2022.
• A 5-year average of $3.3 million and a median of $3.8 million in 2023 frame the typical range for Other Non-Current Assets.
• Across the five-year window, Other Non-Current Assets plunged 51.5% in 2022 and jumped 734.71% in 2024, its largest moves.
• Tracing IRWD's Other Non-Current Assets over 5 years: stood at $485000.0 in 2022, then surged by 643.92% to $3.6 million in 2023, then jumped by 64.16% to $5.9 million in 2024, then fell by 23.99% to $4.5 million in 2025, then declined by 8.11% to $4.1 million in 2026.
• Business Quant data shows IRWD's Other Non-Current Assets at $4.1 million in Q1 2026, $4.5 million in Q4 2025, and $4.8 million in Q3 2025.